نتایج جستجو برای: سوییچ ovs

تعداد نتایج: 482  

2015
Ipshita Bhattacharya Mathews Jacob

Fig (1) : The top row shows NAA maps reconstructed using least squares and proposed method. The spectra are shown at the pixels marked in the water image. The lipid leakage is severe in LS recon. Spectra from the proposed method(in black) are devoid of lipids. Spectra from a fat suppressed data (using 8 OVS bands and residual baseline removal) are overlaid to compare performance against fat sup...

2017

Submit Manuscript | http://medcraveonline.com only recently that clinical trials demonstrated the effectiveness of OVs in humans with recent US Food and Drug Administration (FDA) approval of an oncolytic virus in advanced melanoma [2]. Oncolytic viruses open a new era in cancer treatment. This short article provides a comprehensive overview of Oncolytic viruses, their use as cancer therapeutic ...

2016
KJ Allan David F Stojdl SL Swift

High-throughput screens can rapidly scan and capture large amounts of information across multiple biological parameters. Although many screens have been designed to uncover potential new therapeutic targets capable of crippling viruses that cause disease, there have been relatively few directed at improving the efficacy of viruses that are used to treat disease. Oncolytic viruses (OVs) are biot...

2018
Adel Samson Matthew J Bentham Karen Scott Gerard Nuovo Abigail Bloy Elizabeth Appleton Robert A Adair Rajiv Dave Adam Peckham-Cooper Giles Toogood Seishi Nagamori Matthew Coffey Richard Vile Kevin Harrington Peter Selby Fiona Errington-Mais Alan Melcher Stephen Griffin

OBJECTIVE Oncolytic viruses (OVs) represent promising, proinflammatory cancer treatments. Here, we explored whether OV-induced innate immune responses could simultaneously inhibit HCV while suppressing hepatocellular carcinoma (HCC). Furthermore, we extended this exemplar to other models of virus-associated cancer. DESIGN AND RESULTS Clinical grade oncolytic orthoreovirus (Reo) elicited innat...

2017
Christian Bressy Eric Hastie Valery Z. Grdzelishvili

Oncolytic virus (OV) therapy utilizes replication-competent viruses to kill cancer cells, leaving non-malignant cells unharmed. With the first U.S. Food and Drug Administration-approved OV, dozens of clinical trials ongoing, and an abundance of translational research in the field, OV therapy is poised to be one of the leading treatments for cancer. A number of recombinant OVs expressing a trans...

Journal: :Revue scientifique et technique 2015
C J van Gelderen M Durrieu A A Schudel

The organisation and structure of the official Veterinary Services (OVS) are designed to meet a specific aim--the health certification of animal health, welfare and food safety in the production and processing stage. Disease prevention and control calls for programmes and projects that, depending on the characteristics of each disease, may involve any branch of the OVS, from the laboratory to f...

2017
Tiantian Zhang Yogesh R. Suryawanshi Helene M. Woyczesczyk Karim Essani

Melanoma is the deadliest skin cancer with ever-increasing incidence. Despite the development in diagnostics and therapies, metastatic melanoma is still associated with significant morbidity and mortality. Oncolytic viruses (OVs) represent a class of novel therapeutic agents for cancer by possessing two closely related properties for tumor reduction: virus-induced lysis of tumor cells and induc...

2017
Anwen Howells Giulia Marelli Nicholas R. Lemoine Yaohe Wang

Oncolytic viruses (OVs) are an emerging treatment option for many cancer types and have recently been the focus of extensive research aiming to develop their therapeutic potential. The ultimate aim is to design a virus which can effectively replicate within the host, specifically target and lyse tumor cells and induce robust, long lasting tumor-specific immunity. There are a number of viruses w...

Journal: :Molecular therapy : the journal of the American Society of Gene Therapy 2015
Laura Evgin Sergio A Acuna Christiano Tanese de Souza Monique Marguerie Chantal G Lemay Carolina S Ilkow C Scott Findlay Theresa Falls Kelley A Parato David Hanwell Alyssa Goldstein Roberto Lopez Sandra Lafrance Caroline J Breitbach David Kirn Harold Atkins Rebecca C Auer Joshua M Thurman Gregory L Stahl John D Lambris John C Bell J Andrea McCart

Oncolytic viruses (OVs) have shown promising clinical activity when administered by direct intratumoral injection. However, natural barriers in the blood, including antibodies and complement, are likely to limit the ability to repeatedly administer OVs by the intravenous route. We demonstrate here that for a prototype of the clinical vaccinia virus based product Pexa-Vec, the neutralizing activ...

Journal: :Chinese Journal of Catalysis 2023

The H2 evolution is generally considered a competing reaction in photocatalytic CO2 reduction (CO2RR) using H2O as the proton source. However, reducing gas generated from splitting can be source CO2RR under enhanced dynamic role of thermal effect. reverse water shift (RWGS) reaction, hydrogenation should occur photothermal environment owing to thermodynamically and kinetically favorable. Herein...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید